SCHEMBL6977018

SCHEMBL6977018

COc1cc(NS(=O)(=O)c2ccc(F)cc2)ccc1CO

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.60
LMNA P02545 6/20 0.60
MAPT P10636 2/20 0.60
SMN1; SMN2 Q16637 3/20 0.55
HTT P42858 3/20 0.55
MAPK1 P28482 2/20 0.53
ALOX15 P16050 1/20 0.53
KDM4E B2RXH2 2/20 0.51
HSD17B3 P37058 1/20 0.50
HSD17B2 P37059 1/20 0.50
ALOX12 P18054 1/20 0.49
METAP2 P50579 1/20 0.49
POLB P06746 2/20 0.49
GHSR Q92847 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
THRB P10828 1/20 0.48
PKM P14618 1/20 0.48
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981573 0.88 ALDH1A1 (0.61) ALDH1A1LMNAMAPTSMN1; SMN2HTT
SCHEMBL6795551 0.84 LMNA (0.77) ALDH1A1LMNAMAPTSMN1; SMN2HTT
SCHEMBL6981946 0.80 HSD17B3 (0.68) ALDH1A1SMN1; SMN2MAPK1HSD17B3HSD17B2
SCHEMBL2888624 0.80 HSD17B3 (0.53) ALDH1A1SMN1; SMN2MAPK1HSD17B3HSD17B2
SCHEMBL6979802 0.80 LMNA (0.60) ALDH1A1LMNAMAPTSMN1; SMN2HTT
SCHEMBL12436012 0.76 LMNA (0.50) ALDH1A1LMNAMAPTSMN1; SMN2HTT
SCHEMBL6981258 0.75 HSD17B3 (0.57) ALDH1A1LMNAMAPTHTTMAPK1
SCHEMBL6976064 0.74 ALDH1A1 (0.60) ALDH1A1LMNAMAPTKDM4EMETAP2
SCHEMBL696497 0.74 PDCD1 (0.50) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL31280042 0.74 PDCD1 (0.50) ALDH1A1MAPTSMN1; SMN2HTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed